Pressemeddelelse

Realheart reports insider purchase of the share within the company's board of directors

On November 24, Oskar Mellgren, Chairman of the Board of Scandinavian Real Heart, acquired 7,200 shares in the company.

The shares were purchased at a price of SEK 14 each, corresponding to a total transaction amount of SEK 100,800. The transaction was carried out on Nasdaq First North Growth Market and is listed in the Swedish Financial Supervisory Authority's transparency register.
After the purchase, Oskar now holds a total of 7,200 shares in the company.

About Us
Scandinavian Real Heart AB (publ) is developing the first artificial heart that mimics the shape, function, and blood flow pattern of the human heart. These unique product features provide completely new opportunities to save lives and give patients a good quality of life while waiting for a heart transplant. In the future, artificial hearts may also become an alternative to transplantation for broader groups of patients with severe heart failure. Realheart® TAH (Total Artificial Heart) is now being evaluated in extensive preclinical trials ahead of a first clinical study in patients. The company's shares are traded on Nasdaq Stockholm First North Growth Market. For more information, visit www.realheart.se